[
    {
      "id": "RS-301",
      "content": "IND application for ‘NeoCure’ Phase II expansion. Submitted to Agency X. Additional safety data required.",
      "metadata": "Ref: PR-101, submission date: 2025-02-05, status: Under review"
    },
    {
      "id": "RS-302",
      "content": "Fast-track request for ‘Viraxin-B.’ Preliminary efficacy in animal models. Agency response pending.",
      "metadata": "Ref: PR-102, filed: 2025-01-30, classification: confidential"
    },
    {
      "id": "RS-303",
      "content": "510(k) submission for injection device integration (PR-104). US FDA needs design verification docs.",
      "metadata": "Submitted: 2025-02-20, synergy with MedTech, next milestone: Q3 2025"
    },
    {
      "id": "RS-304",
      "content": "ANDA for generic antibiotic ‘Ampiclox-XYZ’ (PR-105). Stability data included. Potential 3-year shelf life label.",
      "metadata": "Filing date: 2025-03-05, bridging from reference product, code: ANDA-AMP"
    },
    {
      "id": "RS-305",
      "content": "Supplemental NDA for patch formula changes (Analge-Patch). Seeks less skin irritation claim.",
      "metadata": "Ref: PR-103, filed: 2025-02-25, waiting lab toxicity results"
    }
  ]
  